Mycobacterium elephantis was isolated from a human respiratory specimen in April 1999, demonstrating its presence in Europe. The biochemical reaction results, antimicrobial susceptibility pattern, and sequence data for this strain are all in agreement with those of M. elephantis strains isolated previously from other continents (2, 4).
described previously (1) . The sequence was compared against those available from the National Center for Biotechnology Information database (www.ncbi.nlm.nih.gov/entrez), and a similarity index was determined using Gene Compar (Applied Maths, Sint-Martens-Latem, Belgium). There was a 99.8% similarity to M. elephantis (accession number AJ010747). Our identification was confirmed by Dr. E. C. Böttger (Institut für Medizinische Mikrobiologie, Hannover, Germany).
The patient had not experienced any contact with animals and specifically not with elephants from which the first strain of M. elephantis was isolated (2). However, there was a history of respiratory tract infection and enteritis. M. elephantis was isolated only once (but only one mycobacterium culture was performed).
We conclude that further studies are required into the origin, infectiveness, and clinical significance of M. elephantis. In general, clinicians should be aware of the clinical relevance of nontuberculous mycobacterial species, and laboratories should use more advanced methods, including molecular techniques for the identification of mycobacteria not readily identified by standard methods.
